Description of Relugolix Use in Patients With Prostate Cancer Within the VHA

Clinical trial NCT06462014 · COMPLETED

Trial details

NCT number: NCT06462014
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2024-06-19
Primary completion: 2024-12-13
Enrollment: 507

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.